Clinical Trials Browser

Interventional × Atorvastatin × Clear all

NCT04862260 2026-03-19

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Hyperlipoproteinemia Type II, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT04915183 2026-03-09

Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

Phase 2 Recruiting

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Hearing Loss

NCT04767984 2026-01-21

Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis

Phase 2 Active not recruiting

Gastrointestinal

Colitis, Ulcerative, Colorectal Neoplasms

NCT06553157 2026-01-20

Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy

Phase 1/2 Completed

Ototoxicity

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

Phase 2 Recruiting

Breast Neoplasms, Cardiotoxicity

NCT02958852 2025-09-10

ABC-SE

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating

NCT02603328 2025-08-22

AT CASH EPOC

Phase 1/2 Completed

80 enrolled 19 charts

Hemangioma, Cavernous, Central Nervous System

NCT04379999 2025-08-07

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Phase EARLY_PHASE1 Completed

Gastrointestinal

Colorectal Neoplasms, Hereditary Nonpolyposis

NCT05796973 2025-06-27

MOVES

Phase 3 Recruiting

BreastGenitourinaryGynecologic

Breast Neoplasms, Carcinoma, Renal Cell, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms

NCT03819101 2025-06-26

PEACE-4

Phase 3 Recruiting

Prostatic Neoplasms

NCT02943590 2025-05-15

STOP-CA (Statins TO Prevent the Cardiotoxicity From Anthracyclines)

Phase 2 Completed

300 enrolled 13 charts

Heart Failure

NCT04789057 2025-05-08

Captain

Phase 4 Recruiting

Smoking, Pulmonary Disease, Chronic Obstructive

NCT06102863 2025-04-29

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT04904536 2025-04-10

STRONGER

Phase 3 Active not recruiting

COVID-19, Lymphoma, Follicular, Neurologic Manifestations

NCT03127631 2025-01-31

RADICALPC

Phase NA Recruiting

Cardiovascular Diseases, Prostatic Neoplasms

NCT06785974 2025-01-22

SPIRAL

Phase 4 Not yet recruiting

Melanoma, Atherosclerosis

NCT02099123 2024-11-21

STAREE

Phase 4 Active not recruiting

Cardiovascular Diseases, Dementia, Diabetes Mellitus, Neoplasms

NCT03024684 2024-11-12

SHOT

Phase 4 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT03872388 2024-10-02

Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy

Phase 2 Terminated

6 enrolled 8 charts

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05675787 2024-07-11

Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

Endometrial Hyperplasia, Endometrial Neoplasms

NCT06327451 2024-03-25

Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

Phase 2 Recruiting

Glioblastoma

NCT03560882 2024-03-21

A Pilot Trial of Atorvastatin in Tumor Protein 53 (p53) -Mutant and p53 Wild-Type Malignancies

Phase 1 Unknown

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Neoplasms, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT03358017 2023-10-19

YAPPETIZER

Phase 2 Completed

Triple Negative Breast Neoplasms

NCT03830164 2023-10-17

Pentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate Cancer

Phase 2 Completed

14 enrolled 9 charts

Erectile Dysfunction

NCT01980823 2023-08-30

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms

NCT01555632 2023-08-14

Atorvastatin Calcium in Preventing Metabolic Syndrome in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy

Phase NA Withdrawn

Prostatic Neoplasms

NCT05103644 2022-11-02

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Phase 2/3 Unknown

Breast Neoplasms

NCT05507398 2022-10-31

The Anti-tumor Effect of Metformin And Atorvastatin in Breast Cancer

Phase 4 Unknown

Breast Cancer Female

NCT04026230 2022-10-21

ESTO2

Phase 3 Unknown

Prostatic Neoplasms

NCT02201381 2022-07-18

METRICS

Phase 3 Withdrawn

BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT03186404 2022-02-08

SPARE-HF

Phase 2 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

NCT01759836 2022-01-25

Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT01988571 2022-01-04

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Phase 2 Completed

279 enrolled 26 charts

Breast Neoplasms, Lymphoma

NCT03066466 2021-04-27

Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

Phase 3 Withdrawn

LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02497638 2021-04-19

LIGAND

Phase 2 Withdrawn

Prostatic Neoplasms

NCT03275376 2021-03-16

Statin Combination Therapy in Patients Receiving Sorafenib for Advanced Hepatocellular Carcinoma

Phase 2 Terminated

Overall Survival

NCT04601116 2021-01-14

The MASTER Study (MAmmary Cancer STatin ER Positive Study)

Phase 3 Recruiting

Breast Neoplasms

NCT02767362 2020-07-07

A Pre-Op Window Study Evaluating Anti-Proliferative Effects of Atorvastatin on the Endometrium

Phase EARLY_PHASE1 Completed

Endometrial Neoplasms

NCT01527045 2020-01-02

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

Phase 2 Completed

47 enrolled 18 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Myelodysplastic-Myeloproliferative Diseases

NCT04151355 2019-11-05

Effect of Atorvastatin on 5-Fluorouracil Induced Mucositis

Phase NA Unknown

Gastrointestinal

Colorectal Neoplasms

NCT02674204 2019-05-15

STOP

Phase 2 Terminated

2 enrolled 7 charts

Breast Neoplasms, Heart Diseases, Cardiotoxicity

NCT01220973 2018-06-08

Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer

Phase 2 Completed

27 enrolled 6 charts

Prostatic Neoplasms

NCT01821404 2018-05-07

ESTO1

Phase 2 Completed

Inflammation, Prostatic Neoplasms

NCT01491958 2018-01-23

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Phase 2 Completed

40 enrolled 10 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02022293 2017-12-04

Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis

Phase 2 Suspended

Nasopharyngeal Carcinoma, Carotid Stenosis

NCT00185731 2017-12-02

Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma

Phase 2 Completed

25 enrolled 11 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin

NCT02029573 2017-08-18

ART

Phase 2 Completed

Glioblastoma

NCT01525407 2017-08-17

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Phase 2 Completed

83 enrolled 16 charts

Neoplasms

NCT00335504 2017-02-15

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Phase 2 Completed

85 enrolled 10 charts

GastrointestinalOther neoplasm

Colonic Neoplasms, Precancerous Conditions, Rectal Neoplasms

NCT00637481 2016-12-29

A Phase I Prevention Study of Atorvastatin in Women at Increased Risk for Breast Cancer

Phase 1 Completed

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating